Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, par value $0.000001 per share
-
Shares outstanding
-
139,295,316
-
Total 13F shares
-
90,066,890
-
Share change
-
-307,495
-
Total reported value
-
$56,742,224
-
Price per share
-
$0.63
-
Number of holders
-
26
-
Value change
-
-$435,634
-
Number of buys
-
8
-
Number of sells
-
20
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) as of Q2 2024
As of 30 Jun 2024,
Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,066,890 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Altium Capital Management LP, Nantahala Capital Management, LLC, VANGUARD GROUP INC, Juniper Investment Company, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and Crescent Grove Advisors, LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.